Mechanistic study of Idarubicin-induced interferon-signaling

Mechanistic study of Idarubicin-induced interferon-signaling

碩士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 105

Bibliographic Details
Main Authors:	Min-Tsz Huang, 黃敏慈
Other Authors:	Szu-Hao Kung
Format:	Others
Language:	zh-TW
Published:	2017
Online Access:	http://ndltd.ncl.edu.tw/handle/67779051362711780208

Similar Items

Action mechanisms of Idarubicin as an Inducer for Interferon Signaling
by: Pei-Jung Wu, et al.
Published: (2015)

Signal pathways implicated in idarubicin-induced antiviral state
by: Guan-Gun Huang, et al.
Published: (2018)

Protective role of antioxidant vitamin E and catechin on idarubicin-induced cardiotoxicity in rats
by: Kalender S., et al.
Published: (2002-01-01)

Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma
by: Mohamad Chehimi, et al.
Published: (2016-08-01)

Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
by: Abdullah Taşkın, et al.
Published: (2019-10-01)

Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus
by: Pengfei She, et al.
Published: (2020-01-01)

Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3
by: Tomoyoshi Komiyama, et al.
Published: (2016-12-01)

Evaluation of the Protective Effects of Quercetin, Rutin, Naringenin, Resveratrol and Trolox Against Idarubicin-Induced DNA Damage
by: Haydar Çelik, et al.
Published: (2010-07-01)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
by: Boris Guiu, et al.
Published: (2019-07-01)

Carbon-based ruthenium nanomaterial-based electroanalytical sensors for the detection of anticancer drug Idarubicin
by: S. Irem Kaya, et al.
Published: (2020-07-01)

Different influence of Arac combined with idarubicin and with daunorubicin on malignant molecule expression of acute myelocytic leukemia
by: Abudourexiti Nuerbiya, et al.
Published: (2018-05-01)

Dose Dependent Biological Effects of Idarubicin in HL-60 Cells: Alterations of the Cell-Cycle and Apoptosis
by: Martina Mareková, et al.
Published: (2000-01-01)

Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi
by: Momodou Jobe, et al.
Published: (2012-11-01)

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
by: Prajwal Boddu, et al.
Published: (2018-09-01)

Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring
by: Olga Maliszewska, et al.
Published: (2020-12-01)

Immunological Responses against HER2-targeted Idarubicin-ZHER2 Conjugate in BALB/c Mice
by: Leila Siavoshinia, et al.
Published: (2019-10-01)

ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
by: saveria capria, et al.
Published: (2012-01-01)

Analysis of Candidate Idarubicin Drug Resistance Genes in MOLT-3 Cells Using Exome Nuclear DNA
by: Tomoyoshi Komiyama, et al.
Published: (2018-08-01)

ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
by: saveria capria, et al.
Published: (2012-11-01)

High-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferation.
by: Shakti A Goel, et al.
Published: (2014-01-01)

The identification of lung cancer stem cells in malignant pleural effusion and studying their responses to interferon-γ
by: Yu-TszLi, et al.
Published: (2010)

Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation
by: The Staff
Published: (2014-01-01)

Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation.
Published: (2014-01-01)

Optimized Loading of Idarubicin in CalliSpheres<sup>®</sup> Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties
by: Enhao Lu, et al.
Published: (2021-05-01)

Meta-analysis of randomised clinical trials comparing idarubicin + cytarabine with daunorubicin + cytarabine as the induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia.
by: Jing Wang, et al.
Published: (2013-01-01)

Mechanistic Studies of Vertebrate Hedgehog Signaling
by: Tukachinsky, Hanna
Published: (2013)

Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients
by: Chen Tian, et al.
Published: (2021-02-01)

Bioreduction of Idarubicin and Formation of ROS Responsible for DNA Cleavage by NADPH-Cytochrome P450 Reductase and its Potential Role in the Antitumor Effect
by: Haydar Çelik, et al.
Published: (2009-01-01)

Mechanistic Studies of Phorbol ester (TPA) in Signal Transduction of Human Hepatocellular Carcinoma Cells
by: Chang-Hao Huang, et al.
Published: (1999)

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
by: David H Kirn, et al.
Published: (2007-12-01)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
by: Pil Soo Sung, et al.
Published: (2018-09-01)

Idarubicin-loaded methoxy poly(ethylene glycol)-b-poly(L-lactide-co-glycolide) nanoparticles for enhancing cellular uptake and promoting antileukemia activity
by: Liang B, et al.
Published: (2019-01-01)

Mechanistic analysis on KSHV LANA-induced cell migration: Emphasize on microRNAs
by: Tzu-Fang Hu, et al.
Published: (2009)

The first attempt on fabrication of a nano-biosensing platform and exploiting first-order advantage from impedimetric data: Application to simultaneous biosensing of doxorubicin, daunorubicin and idarubicin
by: Shokoufeh Soleimani, et al.
Published: (2020-08-01)

A comparative study of idarubicin 12 mg/m2 and 8 mg/m2 combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients
by: Zhou L, et al.
Published: (2016-02-01)

The role of HGF/c-Met signaling in ultrafine carbon particles-induced proliferation of human pulmonary adenocarcinoma H441 cells
by: Yi-TszLin, et al.
Published: (2012)

The Optimum Dream for Intellectuals─ Writing Personality of "Ｌyu Ye Sian Zong"
by: Min-Tsz Wu, et al.
Published: (2012)

A study on the interferon signaling pathway: the importance of STAT6 in the anti-proliferative effects of type I interferon and the pro-inflammatory effects of miR-155 induced by type II interferon.
by: Hsu, Yu An, et al.
Published: (2017)

Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses
by: Lauren D. Aarreberg, et al.
Published: (2018-03-01)

Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemia
by: Kenneth F. Bradstock, et al.
Published: (2016-12-01)